β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 26 β 19 MARCH 2015
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Neostigmine Methylsulphate Injection
Active Ingredient:
Neostigmine metilsulfate 2.5mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Max Health Limited
Manufacturer:
Hameln Pharmaceuticals GmbH, Hameln, Germany
Product:
Pomalyst
Active Ingredient:
Pomalidomide 1mg
Dosage Form:
Capsule
New Zealand Sponsor:
Celgene Limited
Manufacturers:
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom
Product:
Pomalyst
Active Ingredient:
Pomalidomide 2mg
Dosage Form:
Capsule
New Zealand Sponsor:
Celgene Limited
Manufacturers:
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom
Product:
Pomalyst
Active Ingredient:
Pomalidomide 3mg
Dosage Form:
Capsule
New Zealand Sponsor:
Celgene Limited
Manufacturers:
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom
Product:
Pomalyst
Active Ingredient:
Pomalidomide 4mg
Dosage Form:
Capsule
New Zealand Sponsor:
Celgene Limited
Manufacturers:
Celgene International Sarl, Boudry, Switzerland
Penn Pharmaceutical Services Limited, Gwent, United Kingdom
Dated this 12th day of March 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go1552
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Ilaris
Active Ingredient:
Canakinumab 150mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturers:
Novartis Pharma Stein AG, Stein, Switzerland
Hameln Pharmaceuticals GmbH, Hameln, Germany
40
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare12 March 2015
Medicines, Distribution, Consent, Medicines Act 1981
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare12 March 2015
Medicines, Distribution, Consent, Medicines Act 1981
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 26